- Home
- / Newbury Pharmaceuticals
Newbury Pharmaceuticals
Stock Price
KR4
2024-10-28
Market Capitalization
KR97 M
2024-10-28
Revenue
KR31.6 M
FY, 2025
Newbury Pharmaceuticals Summary
Company Summary
- Overview
- Newbury Pharmaceuticals is a pharmaceutical company for specialty prescription drugs. It specializes in the therapeutic areas of oncology, rare diseases, and neurology.
- Type
- Public
- Status
- Active
- Founded
- 2020
- HQ
- Lund, SE | view all locations
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Lund, Skåne län HQ
Sweden
Scheeletorget 1
Newbury Pharmaceuticals Financials
Summary Financials
- Revenue (Q2, 2026)
- kr8.5M
- Gross profit (Q2, 2026)
- kr3.3M
- Net income (Q2, 2026)
- (kr4.6M)
- Cash (Q2, 2026)
- kr10.1M
- EBIT (Q2, 2026)
- (kr4.1M)
- Enterprise value
- $90.6M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026